Benchmark Reiterates Buy Rating on Abbott Labs (ABT) Ahead of Q2 Results
Tweet Send to a Friend
Benchmark analyst Bruce D. Jackson reiterated a Buy rating and $120.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
